Long-term fibrosis improvement after sustained virologic response in patients with chronic hepatitis C and advanced fibrosis or cirrhosis - pre-treatment cirrhosis, older age and high body mass index increases the risk for persisting fibrosis

被引：0
|
作者：
Hedenstierna, M. [1 ,2 ]
Nangarhari, A. [1 ]
Weiland, O. [1 ,3 ]
Aleman, S. [1 ,4 ]
机构：
[1] Karolinska Inst, Dept Med, Stockholm, Sweden
[2] Danderyds Sjukhus, Dept Infect Dis, Stockholm, Sweden
[3] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden
[4] Karolinska Univ Hosp, Dept Gastroenterol & Hepatol, Stockholm, Sweden
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)31384-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-190
引用
收藏
页码：S493 / S494
页数：2
相关论文
共 48 条
  • [1] Cirrhosis, high age and high body mass index are risk factors for persisting advanced fibrosis after sustained virological response in chronic hepatitis C
    Hedenstierna, M.
    Nangarhari, A.
    El-Sabini, A.
    Weiland, O.
    Aleman, S.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (07) : 802 - 810
  • [2] Regression of Advanced Fibrosis or Cirrhosis Measured by Elastography in Patients with Chronic Hepatitis C who Achieve Sustained Virologic Response after Treatment for HCV
    Crissien, Ana Maria
    Minteer, William B.
    Pan, Jason J.
    Frenette, Catherine T.
    Pockros, Paul J.
    HEPATOLOGY, 2015, 62 : 264A - 265A
  • [3] Comparison of sustained virologic response rates after hepatitis C virus treatment in patients with advanced fibrosis or cirrhosis at an urban academic medical center
    Martin, Michelle T.
    Rosenfeld, Darby
    Lee, Todd
    PHARMACOTHERAPY, 2017, 37 (12): : E184 - E185
  • [4] Long-Term Treatment With Entecavir Induces Reversal of Advanced Fibrosis or Cirrhosis in Patients With Chronic Hepatitis B
    Schiff, Eugene R.
    Lee, Samuel S.
    Chao, You-Chen
    Yoon, Seung Kew
    Bessone, Fernando
    Wu, Shun-Sheng
    Kryczka, Wieslaw
    Lurie, Yoav
    Gadano, Adrian
    Kitis, George
    Beebe, Suzanne
    Xu, Dong
    Tang, Hong
    Iloeje, Uchenna
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (03) : 274 - U111
  • [5] Long-term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis B
    Xu, Bei
    Lin, Lanyi
    Xu, Guoguang
    Zhuang, Yan
    Guo, Qing
    Liu, Yunye
    Wang, Hui
    Zhou, Xiaqiu
    Wu, Shanming
    Bao, Shisan
    Cai, Wei
    Xie, Qing
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (02) : 372 - 378
  • [6] High body mass index hinders fibrosis improvement in patients receiving long-term tenofovir therapy in hepatitis B virus-related cirrhosis
    Chon, Young Eun
    Jung, Kyu Sik
    Ha, Yeonjung
    Kim, Mi Na
    Lee, Joo Ho
    Hwang, Seong Gyu
    Ahn, Sang Hoon
    Kim, Do Young
    Han, Kwang-Hyub
    Park, Jun Yong
    JOURNAL OF VIRAL HEPATITIS, 2020, 27 (11) : 1119 - 1126
  • [7] Fibrosis regression in hepatitis C patients with cirrhosis: Ishak fibrosis score and CPA pre treatment predict regression post sustained virological response
    Nieddu, Paolo
    Dhar, Ameet
    Goldin, Robert D.
    Ladep, Nimzing
    Khan, Sarosh
    Thursz, Mark R.
    Brown, Ashley S.
    HEPATOLOGY, 2014, 60 : 422A - 422A
  • [8] High body mass index is associated with advanced hepatic fibrosis in patients with chronic hepatitis C
    Metwally, M
    Zein, C
    Zein, N
    JOURNAL OF HEPATOLOGY, 2002, 36 : 240 - 240
  • [9] Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis
    Chon, Young Eun
    Park, Jun Yong
    Myoung, Sung-Min
    Jung, Kyu Sik
    Kim, Beom Kyung
    Kim, Seung Up
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (06): : 882 - 891
  • [10] Risk of hepatocellular carcinoma after sustained virologic response in hepatitis C virus patients without advanced liver fibrosis
    Tahata, Yuki
    Sakamori, Ryotaro
    Yamada, Ryoko
    Kodama, Takahiro
    Hikita, Hayato
    Nozaki, Yasutoshi
    Oshita, Masahide
    Hiramatsu, Naoki
    Miyazaki, Masanori
    Mita, Eiji
    Yamamoto, Keiji
    Ohkawa, Kazuyoshi
    Kaneko, Akira
    Ito, Toshifumi
    Doi, Yoshinori
    Yakushijin, Takayuki
    Hijioka, Taizo
    Fukui, Hiroyuki
    Imanaka, Kazuho
    Yoshida, Yuichi
    Yamada, Yukinori
    Tatsumi, Tomohide
    Takehara, Tetsuo
    HEPATOLOGY RESEARCH, 2022, 52 (10) : 824 - 832
12345